BTK Recombinant Rabbit mAb (SDT-2105-37)

產(chǎn)品型號(hào)：S0B2376

更新時(shí)間：2025-07-02

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：64

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

大鼠免疫球蛋白的結(jié)構(gòu)與功能研究

IHC腫瘤標(biāo)志物 | 常見(jiàn)前列腺癌診斷

IHC腫瘤標(biāo)志物 | 常見(jiàn)肺癌診斷

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風(fēng)險(xiǎn)中的診斷潛力

產(chǎn)品介紹

Bruton's tyrosine kinase （BTK） is a non-receptor tyrosine kinase that plays a crucial role in B-cell development and function. It is encoded by the BTK gene and consists of five distinct structural domains, including a kinase domain. BTK is essential for transmitting signals from B-cell antigen receptors, leading to processes like calcium mobilization and B-cell maturation. Mutations in the BTK gene can cause X-linked agammaglobulinemia （XLA）, an immunodeficiency characterized by a lack of mature B cells and antibodies. In addition to its role in B cells, BTK is also involved in mast cell activation and has been implicated in various cancers, where its abnormal activation can lead to uncontrolled B-cell proliferation. Due to its involvement in B-cell signaling and cancer, BTK has become an important target for therapeutic interventions.

上一個(gè)：S0G0008Phospho-GSK-3β (Ser9) Antibody Duo